Pharma Journalist -

Er-Kim, an international pharmaceutical company focused on commercializing novel therapies across the EMEA region, has entered into a distribution agreement with Sentynl Therapeutics,…
Read More...

Biostar Pharma, the U.S. subsidiary of Beijing Biostar Biopharmaceutical, announced that its core drug candidate, Utidelone, has been granted Orphan Drug Designation (ODD) by the U.S.…
Read More...

Eli Lilly and Company has officially opened its newest Lilly Gateway Labs (LGL) location in San Diego, California, marking an expansion of its shared innovation hubs that support…
Read More...

Synaffix B.V., a Lonza company focused on advancing clinical-stage antibody-drug conjugate (ADC) technologies, has entered into a licensing agreement with South Korea–based…
Read More...

Basilea Pharmaceutica Ltd, a commercial-stage biopharmaceutical company based in Allschwil, Switzerland, announced that it has been awarded a contract by the U.S. Biomedical Advanced…
Read More...

Harmony Biosciences Holdings, Inc. has released topline results from its Phase 3 RECONNECT Study evaluating ZYN002, a transdermal cannabidiol gel, in patients with Fragile X syndrome…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Inluriyo (imlunestrant, 200 mg tablets), a new oral treatment from Eli Lilly and Company, for adults with estrogen…
Read More...

Eli Lilly and Company announced that the European Commission has granted marketing authorization for Kisunla (donanemab) to treat adults with early symptomatic Alzheimer’s disease (AD),…
Read More...

Cellectar Biosciences, a late-stage clinical biopharmaceutical company specializing in cancer drug development, has entered into an agreement with Evestia Clinical to provide full…
Read More...

AstraZeneca and Daiichi Sankyo have announced that the U.S. Food and Drug Administration (FDA) has accepted their supplemental Biologics License Application (sBLA) for Enhertu…
Read More...